21，Gavg R,Yusuf S.Overview of randomized trial of angiotensin -converting enzyme inhibitors on mortality and morbidity in patients with heart failure.Collaborative Group on ACE inhibitors.JAMA,1995;273(18):1450
32，CIBIS-Ⅱ Investigators and Committees.The cardiac insufficiency bisoprolol study Ⅱ(CIBIS-Ⅱ)a randomised trial.Lancet,1999;353(9146):9
43，MERIT-HF Study Group.Effect of metoprolol CR/XL in chronic heart failure:Metoprolol CR/XL Randomised Intervention Trial in congestive Heart Failure(MERIT-HF).Lancet,1999;353(9169):2001
5Hamroff G,Blaufarb I,Mancini D,et al.Angiotensin II-receptor blockade further reduces afterload safely in patients maximally treat with angiotensin-converting enzyme inhibitors for heart failure[].Journal of Cardiovascular Pharmacology.1997
6Krombach RS,Clair MJ,Hendrick JW,et al.Angiotensin converting enzyme inhibition, AT1 receptor inhibition, and combination therapy with pacing induced heart failure: effects on left ventricular performance and regional blood flow patterns[].Cardiovascular Research.1998
7Baruch L,Anand I,Cohen IS,et al.Augmented short-and long-term hemodynamic and hormonal effects of an angiotensin receptor blocker added to angiotensin converting enzyme inhibitor therapy in patient with heart failure[].Circulation.1999
8Lang RM,Elkayam U,Yellen LG,et al.Comparative effects of losartan and enalapril on exercise capacity and clinical status in patients with heart failure[].Journal of the American College of Cardiology.1997
9McKelvie RA,Yusuf S,Pericak D,et al.Comparison of candesartan,enalapril, and their combination in congestive heart failure[].Circulation.1999
10Hamroff G,Blaufarb I,Mancini D,et al.Maximally recommended doses of ACE inhibitors do not completely prevent ACE-mediated formation of Ang II in CHF[].Circulation.2000
